EUVIMEDEUVIMED entdecken
Crossref

Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer

Emmanouil Panagiotou, Ioannis Athanasios Vathiotis, Austin Montgomery, Camille Moeckel, Mirsini Livanou, Michail Mastrogeorgiou, Athanasios Trimis, Ioannis Trontzas, Nikolaos Konstantinos Syrigos, Ioannis Mouratidis, Georgios Evangelou, Ilias Georgakopoulos-Soares und 1 weitere

Clinical and Translational Oncology · 31.10.2025 · 28 (4) · 1267-1276

DOI: 10.1007/s12094-025-04097-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, erschienen am 31.10.2025. Verfasst von Emmanouil Panagiotou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, 152, Mesogion Av…. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Biomarkers, Tumor, Immunotherapy. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsBiomarkers, TumorImmunotherapyHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAged, 80 and overAntibodies, Monoclonal, HumanizedProgression-Free SurvivalAdultImmune Checkpoint InhibitorsNeoplasm StagingSurvival RateAntineoplastic Combined Chemotherapy ProtocolsB7-H1 Antigen

Stichwörter der Autor:innen

AtezolizumabDurvalumabImmune checkpoint inhibitorsImmunotherapyRetrospective studiesSmall cell lung carcinoma

Substanzen

Biomarkers, TumoratezolizumabAntibodies, Monoclonal, HumanizedImmune Checkpoint InhibitorsB7-H1 Antigen

Autor:innen und Institutionen

  • Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, 152, Mesogion Ave., 11527, Athens, Greece.
  • Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, 152, Mesogion Ave., 11527, Athens, Greece. johnvathiotis1@gmail.com.
  • Institute for Personalized Medicine, Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
  • Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.

Zitieren

APA

Panagiotou, E., Vathiotis, I. A., Montgomery, A., Moeckel, C., Livanou, M., Mastrogeorgiou, M., Trimis, A., Trontzas, I., Syrigos, N. K., Mouratidis, I., Evangelou, G., Georgakopoulos-Soares, I., & Syrigos, K. N. (2025). Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04097-4

Vancouver

Panagiotou E, Vathiotis IA, Montgomery A, Moeckel C, Livanou M, Mastrogeorgiou M, et al. Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04097-4

BibTeX
@article{Panagiotou2025,
  author = {Panagiotou, Emmanouil and Vathiotis, Ioannis Athanasios and Montgomery, Austin and Moeckel, Camille and Livanou, Mirsini and Mastrogeorgiou, Michail and Trimis, Athanasios and Trontzas, Ioannis and Syrigos, Nikolaos Konstantinos and Mouratidis, Ioannis and Evangelou, Georgios and Georgakopoulos-Soares, Ilias and Syrigos, Konstantinos Nikolaos},
  title = {Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer},
  journal = {Clinical and Translational Oncology},
  year = {2025},
  doi = {10.1007/s12094-025-04097-4}
}
Kostenlos starten →